I don't agree there is a rort. In my onion the approval of drugs is clearly not certain and years away. Daybue long term earnings not yet proven as well. I regularly listen to Aus Biz the call. The guests on the call often talk about looking at a company's profitability over 5 years before investing. NEU's long term profitability is not yet proven. That, in addition to the fact that the whole market volunes are down in the moment explains low volumes and subsequently subdued share price. In my opinion.
I don't agree there is a rort. In my onion the approval of drugs...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.45 |
Change
0.350(1.74%) |
Mkt cap ! $2.579B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $1.259M | 61.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 104 | $20.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.45 | 37 | 5 |
View Market Depth
| Last trade - 13.01pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |